Mayo Clinic's Accurate Amyloidosis Typing Test Leads to Effective Treatment - Insights
When the type of amyloidosis is appropriately determined by accurate and effective laboratory testing, it can be treated properly.
Tissue testing for COVID-19 - Insights
Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic...
Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights
This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.
Mayo Clinic Laboratory and pathology research roundup: June 27 - Insights
This week's research roundup feature: SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.
Mayo Clinic Laboratory and pathology research roundup: August 8 - Insights
This week's research roundup feature: Age-based versus young-adult thresholds for nephrosclerosis on kidney biopsy and prognostic implications for CKD.
Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights
This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Breath Diagnostics, Inc. and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The two...
While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...
Connect with us at the 65th American Society of Hematology Annual Meeting and Exposition to learn how our evaluations can inform your clinical practice. Schedule a one-on-one session with our representatives.
Exocrine pancreatic insufficiency - Insights
Stool testing is a critical component of diagnosing exocrine pancreatic insufficiency (EPI), and Mayo Clinic Laboratories offers several tests to help clinicians evaluate these patients. A 48- or 72-hour stool fecal fat test is useful for...